related documents
- Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes Conference Paper
- Combined antiplatelet and anticoagulant therapy: clinical benefits and risks Conference Paper
- Factor Xa or thrombin: Is thrombin a better target? Conference Paper